Jacqueline Bandwynne notified ImmunoCellular Therapeutics, Ltd. on August 7, 2012 that she will resign from the board of directors effective as of the date of the upcoming 2012 Annual Meeting of Stockholders, expected to be held on September 24, 2012. Ms. Brandwynne has informed the company that her resignation is due to personal time constraints.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.198 USD | +10.61% | +23.75% | -14.66% |
1st Jan change | Capi. | |
---|---|---|
-14.66% | 2.03Cr | |
+51.72% | 6.39TCr | |
-2.41% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.49% | 2.65TCr | |
-21.56% | 1.87TCr | |
+2.49% | 1.27TCr | |
+21.65% | 1.21TCr | |
+28.01% | 1.21TCr |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- Jacqueline Bandwynne to Resign from ImmunoCellular Therapeutics, Ltd. as Director